Fig. 5From: Fabrication and characterization of tretinoin-loaded nanofiber for topical skin deliveryIn-vitro antibacterial activity of formulations B (tretinoin 1% w/v), D (Tretinoin 1% w/v and Erythromycin 0.7%w/v) and E (Erythromycin 0.7% w/v) against S. aureus (ATCC® 25,923™) and S. aureus (ATCC® 29,213™). For formulation D and E there is no significant difference in the zone of inhibitionBack to article page